Background: RYR2, encoding cardiac ryanodine receptor, is the major responsible
| INTRODUC TI ON
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is characterized by exercise or emotion-induced polymorphic or bidirectional ventricular arrhythmias (VAs) leading to syncope or sudden cardiac death in the absence of structural heart disease and is often accompanied by sinus node dysfunction (SND) or sinus bradycardia. (Leenhardt et al., 1995; Postma et al., 2005) (Miyata, Ohno, Itoh, & Horie, 2018) Several responsible genes for CPVT have been identified so far, and RYR2 which encodes the cardiac ryanodine receptor (RyR2) accounts for approximately 60% of CPVT cases. (Laitinen et al., 2001; Priori et al., 2001 ).
The RyR2 is a calcium (Ca 2+ ) release channel on the sarcoplasmic reticulum (SR) and plays a major role in the regulation of intracellular Ca 2+ homeostasis. (Kushnir & Marks, 2010) In patients with RYR2-related CPVT, intracellular Ca 2+ overload due to an increased diastolic Ca 2+ leakage from SR in the presence of high β-adrenergic tone has been thought to be the cause of enhanced U-waves on electrocardiogram (ECG) and VAs which may be coincident with delayed afterdepolarization (DAD)-induced triggered activity. (Katra & Laurita, 2005; Katra, Oya, Hoeker, & Laurita, 2007; Lieve, van der Werf, & Wilde, 2016; Paavola et al., 2007; Viitasalo et al., 2008) .
On the other hand, KCNJ2, encoding inward-rectifier potassium current (I K1 ), has also been reported to be responsible for an atypical type of CPVT, (Tester et al., 2006) although KCNJ2 is typically responsible for Andersen-Tawil syndrome (ATS) characterized by (a) VAs with prominent U-waves (≥0.2 mV) on baseline ECG, (b) periodic paralysis, and (c) dysmorphic features. (Nguyen, Pieper, & Wilders, 2013; Plaster et al., 2001) However, approximately 30% of the disease-causing KCNJ2 variant carriers show only cardiac phenotypes. (Kimura et al., 2012) .
We recently encountered a family with CPVT. Genetic screening of the proband by a targeted panel sequencing using next-generation sequencer (NGS) identified only a rare KCNJ2 E118D variant.
However, after focusing on the read numbers of the NGS, we could identify a novel exon3 deletion of RYR2 (RYR2-exon3 deletion) without performing multiplex ligation-dependent probe amplification (MLPA) method. To elucidate the causative roles of these variants, we investigated family members and functional role of the KCNJ2 E118D variant.
| ME THODS

| Clinical evaluation
The proband (Ⅲ-3) who had CPVT phenotype and her father (Ⅱ-2), mother (Ⅱ-3), paternal aunt (Ⅱ-4), and three children (Ⅳ-1, Ⅳ-2, and Ⅳ-3) were enrolled in this study (Figure 1 ). Baseline
ECGs were available from all the subjects. Prominent U-waves were defined as having U-wave amplitude ≥0.2 mV on baseline ECG. Transthoracic echocardiograms (TTEs) were available from the proband (Ⅲ-3) and her daughter (Ⅳ-3). Hypertrabeculation or left ventricular non-compaction (LVNC) localized at left ventricular apex (LVA) was defined as non-compacted to compacted ratio of ≥2.0 when LVA was observed by short-axis view of TTE as reported by Jenni et al. (Jenni, Oechslin, Schneider, Attenhofer Jost, & Kaufmann, 2001) The proband (Ⅲ-3) and her daughter (Ⅳ-3) underwent exercise stress test using ergometer (30-watt ramp protocol). The proband (Ⅲ-3) underwent isoproterenol infusion test (0.015 μg kg -1 min -1 ). The proband (Ⅲ-3) also underwent left heart catheterization and subsequent acetylcholine provocation to coronary arteries (up to 100 μg), and programmed electrical stimulation up to three extra stimuli from both right ventricular apex and right ventricular outflow tract.
| Genetic analysis
After obtaining appropriate approval from the institutional review board and written informed consent for the genetic analysis from all the subjects of this study, we performed genetic analysis.
Genomic DNA was extracted from peripheral blood lymphocytes as described previously. (Imai et al., 2014) We then performed a targeted panel sequencing of 55 genes of the proband (Ⅲ-3) using NGS (MiSeq, Illumina, San Diego, CA, USA) ( To confirm the CNV in RYR2, we performed long-range PCR using KOD-Plus-Neo (Toyobo, Osaka, Japan). Forward primer (5′-CACAGAACAGGACCAAGTTAGAGGC-3′) and reverse primer (5′-CATTACCTTCCTGACACACTTCATCCTAG-3′) were designed to amplify a region that includes the deleted site of RYR2. The 5' position of the forward primer and the reverse primer was 287,712
and 291,655 in the NCBI Reference Sequence NC_000001.10 (GRCh37), respectively. The PCR products were loaded into 0.8% agarose gels with Tris-Acetate-EDTA buffer and electrophoresed.
Then, the bands were extracted and purified using the QIAquick Gel Extraction Kit (QIAGEN, Hilden, Germany), which were directly sequenced to confirm the precise location of the deletion in RYR2.
Cascade screening of family members, her father (Ⅱ-2), mother (Ⅱ-3), paternal aunt (Ⅱ-4), and three children (Ⅳ-1, Ⅳ-2 and Ⅳ-3), was conducted by a Sanger method and a long-range PCR.
| Mutagenesis and heterologous expression
Human KCNJ2 wild-type (WT) cDNA (NM_000891.1) subcloned into pCMS-EGFP vector (KCNJ2 WT) was used to engineer a KCNJ2 mutant. (Kimura et al., 2012) Site-directed mutagenesis (KCNJ2 
| Electrophysiology
Membrane currents (I K1 ) were recorded using whole-cell patch- Currents were acquired at 20-50 kHz, and low pass-filtered at 5 kHz using an analog-to-digital interface (Digidata 1440A acquisition system, Molecular Devices).
Currents were evoked by 100 ms test pulses applied in 10 mV increments to potentials ranging from −140 mV to +50 mV from a holding potential of −60 mV. Current-voltage (I-V) relationships were obtained by the current amplitudes at the end of 100 ms pulses against test potentials.
| Catecholaminergic stimulation
To resemble the catecholaminergic effect (protein kinase A (PKA) activation) on KCNJ2 WT and KCNJ2 E118D, I K1 was also recorded 5 min after the presence of a PKA cocktail containing 100 μmol/L forskolin (Sigma-Aldrich, Missouri, USA) and 10 μmol/L 3-isobutyl-1-methylxanthine (Sigma-Aldrich, Missouri, USA) in the Bath solution and 10 min after wash out of it as the same method reported by Vega et al. (Vega, Tester, Ackerman, & Makielski, 2009 ).
| Statistical analysis
All data are expressed as mean ± SE, and statistical comparisons were tested using the unpaired Student's t test with p < 0.05 considered to be statistically significant.
| RE SULTS
| Phenotypic manifestations
The proband (Ⅲ-3) (Figure 1 ), a 40-year-old female, experienced cardiopulmonary arrest (CPA) while cycling and then was resuscitated.
Her 12-lead ECG recorded previously at medical examination showed sinus bradycardia (42 bpm) with prominent U-waves (≥0.2 mV) in the anterior precordial leads (Figure 2a ). Echocardiogram showed no AKAP9  ANKB  CACNA1C  CACNA2D1  CACNB2  CALM1   CALM2  CALM3  CAMK2D  CASQ2  CAV3  CTNNA3   DES  DPP6  DSC2  DSG2  DSP  GJA1   GJA5  GPD1L  HCN4  JUP  KCNA5  KCND3   KCNE1  KCNE2  KCNE3  KCNE4  KCNE5  KCNH2   KCNIP2  KCNJ2  KCNJ3  KCNJ5  KCNJ8  KCNN2   KCNQ1  LMNA  MOG1  NCS1  PKP2  RANGRF   RYR2  SCN10A  SCN1B  SCN2B  SCN3B  SCN4B   SCN5A  SLC8A1  SNTA1  TCAP  TMEM4  TRDN   TRPM4 TA B L E 1 Fifty-five genes analyzed by the targeted panel sequencing structural heart diseases except for the presence of hypertrabecula- To confirm it, we conducted long-range PCR using primers designed in intron 2 (forward primer) and intron 3 (reverse primer) of RYR2 as shown in Methods and Figure 4c . Electrophoresis of the PCR products from the control showed single band which size was consistent with an expected one (approximately 3.9 kb) whereas those from the proband showed two distinct bands (Figure 4d ). The size of the upper band from the proband was approximately 3.9 kb identical to that from the control, and the size of the lower band was approximately 2.8 kb (Figure 4d As shown in the pedigree (Figure 1 ), her father (Ⅱ-2) and paternal aunt (Ⅱ-4) were also found to carry both the RYR2-exon3 deletion and KCNJ2 E118D. Her asymptomatic 11-year-old daughter (Ⅳ-3)
carried the RYR2-exon3 deletion alone, but her sons (Ⅳ-1 and Ⅳ-2)
carried neither the RYR2-exon3 deletion nor the KCNJ2 E118D.
| Functional analysis of the KCNJ2 E118D variant
Since KCNJ2 variants can be the cause of an atypical type of CPVT, (Tester et al., 2006) there remained a possibility that the KCNJ2 E118D variant might cause the CPVT phenotype of this We next examined the effects of protein kinase A (PKA) activation on I K1 to resemble the catecholaminergic effect which occurs during exercise-induced VAs. After recording I K1 at baseline condition, I K1 was also recorded in the presence of PKA cocktail (100 μmol/L forskolin +10 μmol/L 3-isobutyl-1-methylxanthine) and after wash out of it, as reported by Vega et al. (Vega et al., 2009) As shown in Figure 6 , PKA activation affected neither KCNJ2 WT nor KCNJ2 E118D. Contrary to the report by Vega et al., (Vega et al., 2009 ) PKA activation did not reduce even I K1 produced by KCNJ2 WT.
| D ISCUSS I ON
| Identification of a rare KCNJ2 E118D variant and a novel exon3 deletion of RYR2
Our genetic screening by the initial targeted panel sequencing on the proband with CVPT identified only a rare KCNJ2 E118D variant. However, focusing on the read numbers of the targeted panel sequencing led us think of the presence of the CNV, then we could finally identify a novel massive deletion of RYR2 including exon3.
An MLPA method has been reported to be useful for identifying CNVs for many diseases including arrhythmogenic disorders. However, it is noteworthy that we identified CNV in RYR2 by ( Barc et al., 2011; Cox et al., 2011; Sonoda et al., 2017 Sonoda et al., , 2018 Therefore, our study underlies the diagnostic importance of examining the read numbers in targeted panel sequencing to rule out the presence of pathological CNVs, even when a conventional method identifies candidate variants that are not actually disease-causing.
Although there have been several reports regarding massive deletion of RYR2 including exon3, direct sequencing of the PCR products (Figure 4e ) from the proband revealed that the deletion site of our RYR2-exon3 deletion was different from those of previous reports. (Bhuiyan et al., 2007; Marjamaa et al., 2009; Medeiros-Domingo et al., 2009; Ohno et al., 2014; Szentpali et al., 2013) .
| Pathophysiological roles of U-waves in patients with CPVT
In patients with RYR2-related CPVT, intracellular Ca 2+ overload or oscillations in the heart are thought to be induced by catecholaminergic stimulation through an increased diastolic Ca 2+ leakage from SR, which may lead to DAD or DAD-induced triggered activity. (Jiang et al., 2004; Katra & Laurita, 2005; Katra et al., 2007; Paavola et al., 2007) Clinical examinations of CPVT patients reported that DADs recorded in monophasic action potential of ventricular myocardium could be augmented by catecholaminergic stimulation, and concomitant U-wave changes on ECG were associated with the DADs. (Nakajima et al., 1997; Paavola et al., 2007) In the present case, catecholaminergic stimulation by isoproterenol infusion augmented Uwaves, followed by PVC. These findings appear to be consistent with these concepts. Intriguingly, Aizawa et al. reported that U-waves in CPVT patients could also be affected by some specific conditions such as after ventricular pacing, after the exercise test and after sinus arrest. (Aizawa et al., 2006) Therefore, there may be a high probability of the relationship between U-waves and arrhythmogenicity in CPVT patients; however, it needs to be further investigated.
| Phenotypic manifestations of this family
The majority of RYR2 variants identified in typical CPVT patients are missense mutations. However, carriers of exon3 deletions of RYR2 have been reported to show a distinct phenotype of CPVT characterized by concomitant SND, AVB, atrial fibrillation, atrial standstill, dilated cardiomyopathy, and LVNC/hypertrabeculation. (Bhuiyan et al., 2007; Marjamaa et al., 2009; Medeiros-Domingo et al., 2009; Ohno et al., 2014; Szentpali et al., 2013) .
In this family, the proband and her elder sister experienced cardiac events during exercise. The proband had sinus bradycardia, prominent U-waves at rest, and hypertrabeculation localized at LVA. Her father and paternal aunt received PPM due to SND, and had prominent U-waves at rest. Her father also had AT with AVB.
These family members, except for her deceased sister, carried both the RYR2-exon3 deletion and the KCNJ2 E118D, which obscured pathophysiological roles of each variant. On the other hand, ECG of her daughter (age 11), who carried only the RYR2-exon3 deletion, showed no prominent U-waves but inverted T-waves. We speculate that normal juvenile pattern of T-waves might obscure U-waves. (Surawicz, 1998) She had been asymptomatic, and exercise stress test induced only one premature ventricular contraction.
Intriguingly, she also had hypertrabeculation at LVA. These various phenotypic manifestations, except for prominent U-waves at rest, of this family appeared to be consistent with those with exon3 deletion of RYR2 in previous reports. (Bhuiyan et al., 2007; Marjamaa et al., 2009; Medeiros-Domingo et al., 2009; Ohno et al., 2014; Szentpali et al., 2013) .
| Possible functional role of the RYR2-exon3 deletion and the KCNJ2 E118D variant
The RYR2-exon3 deletion may produce mutant RyR2 proteins without frameshift, thus may cause their functional abnormalities.
Actually, functional analysis of exon3 deletion of RyR2 using heterologous expression in HEK293 cells or HL-1 cells revealed that it reduced the endoplasmic reticulum or SR luminal Ca 2+ threshold at which Ca 2+ release terminates and increased the fractional Ca 2+ release, and also enhanced the amplitude of store overload-induced Ca 2+ transients. (Tang, Tian, Wang, Fill, & Chen, 2012) Considering it together with clinical reports of patients with exon3 deletion of RYR2, various phenotypic manifestations in this family could be attributable to the RYR2-exon3 deletion. (Bhuiyan et al., 2007; Marjamaa et al., 2009; Medeiros-Domingo et al., 2009; Ohno et al., 2014; Szentpali et al., 2013) .
Regarding the KCNJ2 E118D variant, it caused no functional abnormalities of I K1 based on the patch-clamp study, even in the presence of PKA activation. These findings suggested that prominent U-waves at rest in this family might be associated with the RYR2-exon3 deletion.
| CON CLUS IONS
A novel RYR2-exon3 deletion and a rare KCNJ2 E118D variant were identified in a family with CPVT. The RYR2-exon3 deletion could be identified by focusing on the read numbers of the targeted panel sequencing without performing the MLPA method, which emphasizes the importance of focusing on the read numbers when performing genetic analysis using NGS. The RYR2-exon3 deletion may produce mutant RyR2 proteins without frameshift, thus cause RyR2 dysfunction, but the KCNJ2 E118D variant did not cause I K1 dysfunction.
Therefore, the novel RYR2-exon3 deletion may be associated with phenotypic features of this family.
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